Cartesian Therapeutics Inc. (RNAC)
NASDAQ · Healthcare
Cartesian Therapeutics Inc. Shareholder Equity 2014–2025
Cartesian Therapeutics Inc. annual/quarterly shareholder equity history from 2015 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cartesian Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were -126.2M, a 1755.92% increase year-over-year.
- Cartesian Therapeutics Inc. shareholder equity for 2025 were -126.2M, a 1755.92% increase from 2024.
- Cartesian Therapeutics Inc. shareholder equity for 2024 were -6.8M, a 98.45% decrease from 2023.
- Cartesian Therapeutics Inc. shareholder equity for 2023 were -440.2M, a 569.14% decrease from 2022.
- Cartesian Therapeutics Inc. shareholder equity for 2022 were 93.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cartesian Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-126 |
| 2024 | $-7 |
| 2023 | $-440 |
| 2022 | $94 |
| 2021 | $23 |
| 2020 | $-18 |
| 2019 | $8 |
| 2018 | $-5 |
| 2017 | $52 |
| 2016 | $55 |
| 2015 | $-116 |
| Cartesian Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-126 |
| 2024-12-31 | $-7 |
| 2023-12-31 | $-440 |
| 2022-12-31 | $94 |
| 2021-12-31 | $23 |
| 2020-12-31 | $-18 |
| 2019-12-31 | $8 |
| 2018-12-31 | $-5 |
| 2017-12-31 | $52 |
| 2016-12-31 | $55 |
| 2015-12-31 | $-116 |
Cartesian Therapeutics Inc. Shareholder Equity — FAQ
Cartesian Therapeutics Inc. (RNAC) shareholder equity over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RNAC's shareholder equity history?
The chart and table above show Cartesian Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.